✦ LIBER ✦

c-myc and K-ras-2 oncogenes in B-cell chronic lymphocytic leukemia with del(12)(p13)

✍ Scribed by Tian-you Wang; Don M. Samples; Roberto Dabdoub; Om Prakash

Book ID: 119104802
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 325 KB
Volume: 51
Category: Article
ISSN: 0165-4608
DOI: 10.1016/0165-4608(91)90018-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interphase cytogenetic analysis in Argen

Interphase cytogenetic analysis in Argentinean B-cell chronic lymphocytic leukemia patients: association of trisomy 12 and del(13q14)

✍ Christian Chena; Guillermo Arrossagaray; Mariano Scolnik; Marı́a F Palacios; Irm 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Interferon-α-Mediated Prevention of in V

Interferon-α-Mediated Prevention of in Vitro Apoptosis of Chronic Lymphocytic Leukemia B Cells: Role of bcl-2 and c-myc

✍ Nadia Chaouchi; Christine Wallon; Joelle Taieb; Marie Thérèse Auffredou; Gerard 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 617 KB

MDM2 antagonists activate p53 and synerg

MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells

✍ Coll-Mulet, L. 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 293 KB

Impact of trisomy 12, del(13q), del(17p)

Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia

✍ Sandra Quijano; Antonio López; Ana Rasillo; José María Sayagués; Susana Barrena; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

## Abstract B‐cell chronic lymphocytic leukemia (B‐CLL) is a well‐defined clinical entity with heterogeneous molecular and cytogenetic features. Here, we analyze the impact of trisomy 12, del(13q), del(17p), and del(11q) as determined by interphase fluorescence in situ hybridization analysis of pur

Serum levels of 2′, 5 oligoadenylate syn

Serum levels of 2′, 5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia

✍ Dr. C. Musolino; P. Grosso; A. Alonci; A. Allegra; A. Orlando; M. Cincotta; G. B 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

Rapid tumor lysis in a patient with B-ce

Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)

✍ M. Jensen; U. Winkler; O. Manzke; V. Diehl; A. Engert 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 161 KB